Estonia Pharmaceuticals & Healthcare Q1 2019
Estonia’s pharmaceutical sector is limited by its relatively small size and historically inadequate levels of publicly-fundedhealthcare. In the coming years, we believe growth in the market will be boosted by an increase in healthcare funding as well as thegovernment’s long-term health development plan. We have revised our short- and medium-term outlook for public healthcareexpenditure, boosting drugmaker opportunities.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook